By implicating Nrf2 in hypoxia-induced drug resistance and providing evidence for direct interaction of Nrf2 protein with HIF-1α enhancer, our study has gained significant insights into the underlying mechanisms by which the hypoxic tumor micro-environment causes chemo-resistance. The gene discussed is NFE2L2; the disease is neoplasm.